Digitalisation prompts evolution of healthcare

Digitalisation prompts evolution of healthcare

Burning to take advantage of Vietnam’s new digital transformation in the healthcare sector, international pharma giants like Novartis, AstraZeneca, Sanofi, and GSK are working to align with the new requirements and obtain sustainable gains.
Novartis Vietnam kicks off PPP project to strengthen primary healthcare

Novartis Vietnam kicks off PPP project to strengthen primary healthcare

Novartis Vietnam and Ha Tinh Department of Health and CDC kicked off the project to strengthen primary healthcare in the central province.
Replaced regulation to hit global drugmakers

Replaced regulation to hit global drugmakers

International pharma giants like Pfizer, GSK, and Novartis are expected to be strongly hit soon by a price cut under Vietnam’s new tender rules for branded drugs, enabling local patients to receive an increase in pharmaceutical access at affordable prices.
Novartis agrees to $642mn US settlement over kickbacks

Novartis agrees to $642mn US settlement over kickbacks

Swiss pharmaceutical giant Novartis has agreed to pay more than $642 million to settle a lawsuit which accused it of paying kickbacks to doctors, among other allegations, the US Department of Justice said Wednesday.
Pharma groups to profit from virus?

Pharma groups to profit from virus?

The top 10 global pharmaceutical companies are being scrutinised and advised not to prevent or delay a vaccine for COVID-19 from reaching vulnerable people to gain profits, triggering global concerns over their social responsibility.
Global pharma groups push on with operations

Global pharma groups push on with operations

Despite having risk management solutions to ensure drug import continuity to Vietnam in response to EU border closures, international pharma giants Sanofi, Zuellig Pharma, Adamed, and Novartis are closely monitoring the situation due to the potential direct impacts on long-term supply security.    
US groups flock to ASEAN to further aid business interests

US groups flock to ASEAN to further aid business interests

Betting on Vietnam’s future growth potential driven by landmark free trade agreements, investors from both the United States and the ASEAN are releasing new plans to venture further into the lucrative local market, with healthcare being a heavy focus.
Novartis reaffirming integrity despite accusations

Novartis reaffirming integrity despite accusations

Bribery accusations involving Swiss pharma conglomerate Novartis have triggered suspicions about the firm’s code of ethics when it comes to its Vietnamese operations.
Novartis announces new legal entity to expand in Vietnam

Novartis announces new legal entity to expand in Vietnam

Novartis inaugurated its new legal entity, becoming one of the first MNCs in the country to transform from a representative office to an FIE importer.
Novartis programme benefits thousands of Vietnamese cancer patients

Novartis programme benefits thousands of Vietnamese cancer patients

The Vietnam Medical Association, the MoH, Vietnam Social Insurance, and Novartis Vietnam Co., Ltd. reviewed the programme supporting cancer medicines.
Novartis ventures further into primary healthcare in Vietnam 

Novartis ventures further into primary healthcare in Vietnam 

Novartis signed an MoU with the Ministry of Health on raising primary healthcare in Vietnam through activities at commune and district levels from 2019 to 2021.
Vietnam seeks solutions achieve Universal Healthcare Coverage by 2030

Vietnam seeks solutions achieve Universal Healthcare Coverage by 2030

Vietnam and international partners gathered the first-ever Primary Healthcare Partnership Dialogue on May 16 to discuss ways to strengthen primary healthcare as the foundation to achieve universal healthcare coverage by 2030.
Novartis eyes PPP projects in Vietnam

Novartis eyes PPP projects in Vietnam

Novartis is interested in partnering with the MoH in PPP projects in anticipation of growing local demand for healthcare.
Vietnam to attend Novartis regional stakeholder event in Singapore

Vietnam to attend Novartis regional stakeholder event in Singapore

Novartis Social Business will host its fourth stakeholder dialogue in Singapore, with the participation of more than 100 experts and officials.
1 2